| Product Code: ETC7206159 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Finland continued to source pyruvate kinase primarily from Netherlands, Denmark, Metropolitan France, Japan, and Belgium. The market showed moderate concentration with a stable HHI index. Despite a slight negative CAGR from 2020-24, the growth rate in 2024 surged by 14.69%, indicating a potential uptick in demand for pyruvate kinase imports in Finland. This trend suggests that the market for pyruvate kinase in Finland is dynamic and responsive to changing demands and supply dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Pyruvate Kinase Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Pyruvate Kinase Market - Industry Life Cycle |
3.4 Finland Pyruvate Kinase Market - Porter's Five Forces |
3.5 Finland Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Finland Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about pyruvate kinase deficiency and its diagnosis in Finland |
4.2.2 Growing demand for advanced diagnostic technologies for metabolic disorders |
4.2.3 Rising investments in healthcare infrastructure and research and development in the field of rare diseases |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diagnostic tests and treatments |
4.3.2 Limited availability of skilled healthcare professionals specialized in metabolic disorders in Finland |
5 Finland Pyruvate Kinase Market Trends |
6 Finland Pyruvate Kinase Market, By Types |
6.1 Finland Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Finland Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Finland Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Finland Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Finland Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Finland Pyruvate Kinase Market Export to Major Countries |
7.2 Finland Pyruvate Kinase Market Imports from Major Countries |
8 Finland Pyruvate Kinase Market Key Performance Indicators |
8.1 Number of research studies and clinical trials focusing on pyruvate kinase deficiency in Finland |
8.2 Adoption rate of advanced diagnostic tools for pyruvate kinase deficiency in healthcare facilities |
8.3 Percentage of healthcare professionals in Finland with specialized training in diagnosing and treating metabolic disorders |
9 Finland Pyruvate Kinase Market - Opportunity Assessment |
9.1 Finland Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Finland Pyruvate Kinase Market - Competitive Landscape |
10.1 Finland Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Finland Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |